nodes	percent_of_prediction	percent_of_DWPC	metapath
Modafinil—ADRA1B—polycystic ovary syndrome	0.83	1	CbGaD
Modafinil—Seasonal allergy—Metformin—polycystic ovary syndrome	0.0102	0.115	CcSEcCtD
Modafinil—Rhinitis seasonal—Metformin—polycystic ovary syndrome	0.00979	0.11	CcSEcCtD
Modafinil—Tooth abscess—Metformin—polycystic ovary syndrome	0.00512	0.0576	CcSEcCtD
Modafinil—Loose stools—Metformin—polycystic ovary syndrome	0.00386	0.0435	CcSEcCtD
Modafinil—Body temperature decreased—Metformin—polycystic ovary syndrome	0.00381	0.0429	CcSEcCtD
Modafinil—Hypothermia—Metformin—polycystic ovary syndrome	0.00381	0.0429	CcSEcCtD
Modafinil—Accidental injury—Metformin—polycystic ovary syndrome	0.00242	0.0272	CcSEcCtD
Modafinil—Ear pain—Metformin—polycystic ovary syndrome	0.00182	0.0205	CcSEcCtD
Modafinil—Injury—Metformin—polycystic ovary syndrome	0.00169	0.019	CcSEcCtD
Modafinil—Migraine—Metformin—polycystic ovary syndrome	0.00153	0.0172	CcSEcCtD
Modafinil—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00142	0.016	CcSEcCtD
Modafinil—Influenza—Metformin—polycystic ovary syndrome	0.00134	0.0151	CcSEcCtD
Modafinil—Drowsiness—Metformin—polycystic ovary syndrome	0.0012	0.0135	CcSEcCtD
Modafinil—Bradycardia—Metformin—polycystic ovary syndrome	0.00109	0.0123	CcSEcCtD
Modafinil—Rhinitis—Metformin—polycystic ovary syndrome	0.00108	0.0121	CcSEcCtD
Modafinil—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00106	0.0119	CcSEcCtD
Modafinil—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00105	0.0119	CcSEcCtD
Modafinil—Cardiac disorder—Metformin—polycystic ovary syndrome	0.000996	0.0112	CcSEcCtD
Modafinil—Angiopathy—Metformin—polycystic ovary syndrome	0.000974	0.011	CcSEcCtD
Modafinil—Immune system disorder—Metformin—polycystic ovary syndrome	0.00097	0.0109	CcSEcCtD
Modafinil—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.000968	0.0109	CcSEcCtD
Modafinil—Chills—Metformin—polycystic ovary syndrome	0.000963	0.0108	CcSEcCtD
Modafinil—Malnutrition—Metformin—polycystic ovary syndrome	0.000935	0.0105	CcSEcCtD
Modafinil—Flatulence—Metformin—polycystic ovary syndrome	0.000921	0.0104	CcSEcCtD
Modafinil—Dysgeusia—Metformin—polycystic ovary syndrome	0.000915	0.0103	CcSEcCtD
Modafinil—Muscle spasms—Metformin—polycystic ovary syndrome	0.000898	0.0101	CcSEcCtD
Modafinil—Tremor—Metformin—polycystic ovary syndrome	0.000876	0.00986	CcSEcCtD
Modafinil—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000867	0.00976	CcSEcCtD
Modafinil—Bifonazole—CYP17A1—polycystic ovary syndrome	0.000851	0.2	CrCbGaD
Modafinil—Malaise—Metformin—polycystic ovary syndrome	0.000843	0.00949	CcSEcCtD
Modafinil—Syncope—Metformin—polycystic ovary syndrome	0.000838	0.00944	CcSEcCtD
Modafinil—Palpitations—Metformin—polycystic ovary syndrome	0.000826	0.0093	CcSEcCtD
Modafinil—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000821	0.00925	CcSEcCtD
Modafinil—Hypertension—Metformin—polycystic ovary syndrome	0.000807	0.00909	CcSEcCtD
Modafinil—Myalgia—Metformin—polycystic ovary syndrome	0.000796	0.00896	CcSEcCtD
Modafinil—Chest pain—Metformin—polycystic ovary syndrome	0.000796	0.00896	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00079	0.0089	CcSEcCtD
Modafinil—Discomfort—Metformin—polycystic ovary syndrome	0.000786	0.00885	CcSEcCtD
Modafinil—Oedema—Metformin—polycystic ovary syndrome	0.000763	0.00859	CcSEcCtD
Modafinil—Infection—Metformin—polycystic ovary syndrome	0.000758	0.00853	CcSEcCtD
Modafinil—Shock—Metformin—polycystic ovary syndrome	0.00075	0.00845	CcSEcCtD
Modafinil—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000748	0.00842	CcSEcCtD
Modafinil—Skin disorder—Metformin—polycystic ovary syndrome	0.000741	0.00834	CcSEcCtD
Modafinil—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000737	0.0083	CcSEcCtD
Modafinil—Anorexia—Metformin—polycystic ovary syndrome	0.000727	0.00819	CcSEcCtD
Modafinil—Hypotension—Metformin—polycystic ovary syndrome	0.000713	0.00803	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000695	0.00783	CcSEcCtD
Modafinil—CYP2C19—urine—polycystic ovary syndrome	0.000688	0.196	CbGeAlD
Modafinil—Paraesthesia—Metformin—polycystic ovary syndrome	0.000685	0.00771	CcSEcCtD
Modafinil—Dyspnoea—Metformin—polycystic ovary syndrome	0.00068	0.00766	CcSEcCtD
Modafinil—Somnolence—Metformin—polycystic ovary syndrome	0.000678	0.00764	CcSEcCtD
Modafinil—Dyspepsia—Metformin—polycystic ovary syndrome	0.000671	0.00756	CcSEcCtD
Modafinil—Decreased appetite—Metformin—polycystic ovary syndrome	0.000663	0.00747	CcSEcCtD
Modafinil—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000658	0.00742	CcSEcCtD
Modafinil—Fatigue—Metformin—polycystic ovary syndrome	0.000658	0.00741	CcSEcCtD
Modafinil—Constipation—Metformin—polycystic ovary syndrome	0.000652	0.00735	CcSEcCtD
Modafinil—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000629	0.00708	CcSEcCtD
Modafinil—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000624	0.00702	CcSEcCtD
Modafinil—Urticaria—Metformin—polycystic ovary syndrome	0.000606	0.00682	CcSEcCtD
Modafinil—Abdominal pain—Metformin—polycystic ovary syndrome	0.000603	0.00679	CcSEcCtD
Modafinil—Phenoxybenzamine—ADRA1D—polycystic ovary syndrome	0.000592	0.139	CrCbGaD
Modafinil—CYP1A2—urine—polycystic ovary syndrome	0.000562	0.16	CbGeAlD
Modafinil—Asthenia—Metformin—polycystic ovary syndrome	0.000547	0.00616	CcSEcCtD
Modafinil—Pruritus—Metformin—polycystic ovary syndrome	0.00054	0.00608	CcSEcCtD
Modafinil—CYP2C9—urine—polycystic ovary syndrome	0.000533	0.152	CbGeAlD
Modafinil—Diarrhoea—Metformin—polycystic ovary syndrome	0.000522	0.00588	CcSEcCtD
Modafinil—Phenoxybenzamine—ADRA1B—polycystic ovary syndrome	0.000505	0.119	CrCbGaD
Modafinil—Dizziness—Metformin—polycystic ovary syndrome	0.000504	0.00568	CcSEcCtD
Modafinil—Vomiting—Metformin—polycystic ovary syndrome	0.000485	0.00546	CcSEcCtD
Modafinil—Rash—Metformin—polycystic ovary syndrome	0.000481	0.00542	CcSEcCtD
Modafinil—Dermatitis—Metformin—polycystic ovary syndrome	0.00048	0.00541	CcSEcCtD
Modafinil—Headache—Metformin—polycystic ovary syndrome	0.000478	0.00538	CcSEcCtD
Modafinil—Nausea—Metformin—polycystic ovary syndrome	0.000453	0.0051	CcSEcCtD
Modafinil—Bifonazole—CYP19A1—polycystic ovary syndrome	0.000433	0.102	CrCbGaD
Modafinil—CYP3A4—urine—polycystic ovary syndrome	0.000407	0.116	CbGeAlD
Modafinil—Benzphetamine—ADRA1A—polycystic ovary syndrome	0.000356	0.0837	CrCbGaD
Modafinil—Phenoxybenzamine—ADRA1A—polycystic ovary syndrome	0.00034	0.0799	CrCbGaD
Modafinil—Levomethadyl Acetate—CYP19A1—polycystic ovary syndrome	0.000325	0.0765	CrCbGaD
Modafinil—Warfarin—CYP1A1—polycystic ovary syndrome	0.000255	0.0601	CrCbGaD
Modafinil—Cinnarizine—CYP1A1—polycystic ovary syndrome	0.000202	0.0476	CrCbGaD
Modafinil—Phenoxybenzamine—ADRB2—polycystic ovary syndrome	0.000202	0.0475	CrCbGaD
Modafinil—Methadone—CYP19A1—polycystic ovary syndrome	0.000191	0.0449	CrCbGaD
Modafinil—CYP2B6—adrenal cortex—polycystic ovary syndrome	0.000143	0.0407	CbGeAlD
Modafinil—CYP2C19—vagina—polycystic ovary syndrome	0.000122	0.0348	CbGeAlD
Modafinil—CYP3A5—adipose tissue—polycystic ovary syndrome	0.000115	0.033	CbGeAlD
Modafinil—CYP2C19—endocrine gland—polycystic ovary syndrome	0.000114	0.0326	CbGeAlD
Modafinil—CYP2B6—adrenal gland—polycystic ovary syndrome	0.000103	0.0294	CbGeAlD
Modafinil—CYP3A5—female gonad—polycystic ovary syndrome	9.66e-05	0.0276	CbGeAlD
Modafinil—CYP3A5—vagina—polycystic ovary syndrome	9.6e-05	0.0274	CbGeAlD
Modafinil—CYP2B6—vagina—polycystic ovary syndrome	9.54e-05	0.0272	CbGeAlD
Modafinil—CYP1A2—endocrine gland—polycystic ovary syndrome	9.31e-05	0.0266	CbGeAlD
Modafinil—CYP3A5—endocrine gland—polycystic ovary syndrome	8.98e-05	0.0256	CbGeAlD
Modafinil—CYP2B6—endocrine gland—polycystic ovary syndrome	8.93e-05	0.0255	CbGeAlD
Modafinil—CYP2C9—endocrine gland—polycystic ovary syndrome	8.84e-05	0.0252	CbGeAlD
Modafinil—CYP3A4—endocrine gland—polycystic ovary syndrome	6.74e-05	0.0192	CbGeAlD
Modafinil—ADRA1B—Signaling Pathways—PDE3B—polycystic ovary syndrome	3.24e-05	0.000441	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—SRD5A1—polycystic ovary syndrome	3.21e-05	0.000437	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	3.2e-05	0.000436	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—GHRL—polycystic ovary syndrome	3.16e-05	0.00043	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	3.14e-05	0.000427	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—SRD5A1—polycystic ovary syndrome	3.14e-05	0.000427	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	3.11e-05	0.000423	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	3.07e-05	0.000418	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—STAR—polycystic ovary syndrome	3.07e-05	0.000417	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—AKR1C2—polycystic ovary syndrome	3.06e-05	0.000416	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—TEAD2—polycystic ovary syndrome	3.06e-05	0.000416	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	3.01e-05	0.00041	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	3.01e-05	0.00041	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—STAR—polycystic ovary syndrome	3e-05	0.000407	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	2.99e-05	0.000407	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	2.98e-05	0.000404	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—FSHR—polycystic ovary syndrome	2.95e-05	0.000401	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	2.94e-05	0.0004	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	2.89e-05	0.000393	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—POMC—polycystic ovary syndrome	2.89e-05	0.000393	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	2.89e-05	0.000393	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—GHRL—polycystic ovary syndrome	2.87e-05	0.00039	CbGpPWpGaD
Modafinil—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	2.85e-05	0.000388	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	2.84e-05	0.000386	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	2.8e-05	0.000381	CbGpPWpGaD
Modafinil—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	2.79e-05	0.00038	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	2.79e-05	0.000379	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	2.79e-05	0.000379	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—RACGAP1—polycystic ovary syndrome	2.78e-05	0.000377	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	2.74e-05	0.000372	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—HMMR—polycystic ovary syndrome	2.73e-05	0.000371	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ADRA1A—polycystic ovary syndrome	2.7e-05	0.000367	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	2.68e-05	0.000364	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—HMMR—polycystic ovary syndrome	2.67e-05	0.000363	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	2.64e-05	0.000359	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—FST—polycystic ovary syndrome	2.63e-05	0.000358	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2.62e-05	0.000356	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—HSD3B1—polycystic ovary syndrome	2.61e-05	0.000354	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.6e-05	0.000353	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—LHB—polycystic ovary syndrome	2.57e-05	0.000349	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PNPLA2—polycystic ovary syndrome	2.56e-05	0.000348	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	2.56e-05	0.000347	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—HSD3B1—polycystic ovary syndrome	2.55e-05	0.000346	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	2.54e-05	0.000346	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.51e-05	0.000341	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.43e-05	0.000331	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—SRD5A1—polycystic ovary syndrome	2.43e-05	0.00033	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.43e-05	0.00033	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	2.43e-05	0.00033	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SCT—polycystic ovary syndrome	2.41e-05	0.000327	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	2.38e-05	0.000324	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	2.38e-05	0.000324	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—LHB—polycystic ovary syndrome	2.38e-05	0.000323	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.38e-05	0.000323	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	2.34e-05	0.000318	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	2.33e-05	0.000316	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	2.33e-05	0.000316	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—LHB—polycystic ovary syndrome	2.32e-05	0.000316	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—HSD3B2—polycystic ovary syndrome	2.32e-05	0.000316	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	2.32e-05	0.000315	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.3e-05	0.000312	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	2.29e-05	0.000311	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.29e-05	0.000311	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—HSD3B2—polycystic ovary syndrome	2.27e-05	0.000309	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—FGF18—polycystic ovary syndrome	2.26e-05	0.000307	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	2.25e-05	0.000307	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—AKR1C1—polycystic ovary syndrome	2.25e-05	0.000306	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—RBP4—polycystic ovary syndrome	2.24e-05	0.000304	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	2.23e-05	0.000303	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	2.21e-05	0.000301	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.2e-05	0.0003	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	2.2e-05	0.000299	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	2.16e-05	0.000294	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	2.16e-05	0.000293	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	2.11e-05	0.000287	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—YAP1—polycystic ovary syndrome	2.09e-05	0.000284	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.09e-05	0.000284	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—SULT2A1—polycystic ovary syndrome	2.07e-05	0.000282	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	2.07e-05	0.000281	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—GAB1—polycystic ovary syndrome	2.06e-05	0.00028	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	2.02e-05	0.000275	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—RRM2—polycystic ovary syndrome	2.01e-05	0.000273	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	2e-05	0.000271	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—INSR—polycystic ovary syndrome	1.97e-05	0.000268	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	1.97e-05	0.000268	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	1.96e-05	0.000267	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.95e-05	0.000265	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—YAP1—polycystic ovary syndrome	1.93e-05	0.000263	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	1.89e-05	0.000257	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	1.89e-05	0.000257	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	1.88e-05	0.000256	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.87e-05	0.000255	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—NAMPT—polycystic ovary syndrome	1.86e-05	0.000253	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.85e-05	0.000251	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.84e-05	0.000251	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	1.84e-05	0.00025	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	1.84e-05	0.00025	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYP11A1—polycystic ovary syndrome	1.83e-05	0.000249	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PGR—polycystic ovary syndrome	1.82e-05	0.000248	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	1.82e-05	0.000247	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	1.81e-05	0.000245	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	1.8e-05	0.000244	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	1.8e-05	0.000244	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	1.79e-05	0.000244	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	1.78e-05	0.000243	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.78e-05	0.000241	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	1.76e-05	0.000239	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—AKR1C3—polycystic ovary syndrome	1.73e-05	0.000236	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYP17A1—polycystic ovary syndrome	1.71e-05	0.000232	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	1.7e-05	0.000231	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PLAT—polycystic ovary syndrome	1.7e-05	0.000231	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—GHRL—polycystic ovary syndrome	1.7e-05	0.000231	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	1.69e-05	0.00023	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.68e-05	0.000229	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	1.67e-05	0.000227	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	1.64e-05	0.000223	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.63e-05	0.000222	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ATF1—polycystic ovary syndrome	1.62e-05	0.00022	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	1.61e-05	0.000219	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	1.6e-05	0.000218	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.58e-05	0.000215	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.57e-05	0.000214	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	1.57e-05	0.000213	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	1.55e-05	0.000211	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	1.54e-05	0.000209	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	1.54e-05	0.000209	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.52e-05	0.000206	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	1.52e-05	0.000206	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NGFR—polycystic ovary syndrome	1.49e-05	0.000203	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—POMC—polycystic ovary syndrome	1.48e-05	0.000202	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PRL—polycystic ovary syndrome	1.48e-05	0.000201	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—TH—polycystic ovary syndrome	1.48e-05	0.000201	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	1.46e-05	0.000199	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	1.46e-05	0.000199	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—TH—polycystic ovary syndrome	1.44e-05	0.000196	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.44e-05	0.000196	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—SLC2A4—polycystic ovary syndrome	1.44e-05	0.000195	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	1.43e-05	0.000194	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.43e-05	0.000194	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.4e-05	0.000191	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	1.4e-05	0.000191	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	1.4e-05	0.000191	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	1.4e-05	0.00019	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.4e-05	0.00019	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	1.39e-05	0.000189	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	1.39e-05	0.000188	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	1.38e-05	0.000188	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.38e-05	0.000187	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	1.37e-05	0.000186	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYP19A1—polycystic ovary syndrome	1.35e-05	0.000183	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	1.33e-05	0.000181	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	1.33e-05	0.00018	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	1.32e-05	0.000179	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	1.31e-05	0.000178	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—GNAS—polycystic ovary syndrome	1.3e-05	0.000177	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	1.29e-05	0.000175	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	1.28e-05	0.000174	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.27e-05	0.000173	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	1.26e-05	0.000172	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.25e-05	0.000171	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	1.24e-05	0.000169	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.24e-05	0.000169	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	1.22e-05	0.000166	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NRG1—polycystic ovary syndrome	1.22e-05	0.000165	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GNAS—polycystic ovary syndrome	1.2e-05	0.000164	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	1.19e-05	0.000162	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	1.18e-05	0.000161	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	1.18e-05	0.000161	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	1.18e-05	0.00016	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	1.18e-05	0.00016	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—NCOR1—polycystic ovary syndrome	1.15e-05	0.000156	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	1.14e-05	0.000155	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	1.12e-05	0.000152	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—TH—polycystic ovary syndrome	1.12e-05	0.000152	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	1.09e-05	0.000149	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYP1A1—polycystic ovary syndrome	1.09e-05	0.000148	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.09e-05	0.000148	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	1.08e-05	0.000147	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	1.08e-05	0.000147	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	1.08e-05	0.000147	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.07e-05	0.000146	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	1.06e-05	0.000145	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	1.06e-05	0.000144	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IRS2—polycystic ovary syndrome	1.04e-05	0.000142	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	1.02e-05	0.000139	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—LEP—polycystic ovary syndrome	1.02e-05	0.000139	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	1.02e-05	0.000139	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	1.02e-05	0.000139	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—TH—polycystic ovary syndrome	1.02e-05	0.000138	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—MTHFR—polycystic ovary syndrome	1.01e-05	0.000138	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	1e-05	0.000137	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	9.91e-06	0.000135	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	9.89e-06	0.000134	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	9.41e-06	0.000128	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	9.3e-06	0.000126	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	9.11e-06	0.000124	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	9.1e-06	0.000124	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IRS1—polycystic ovary syndrome	9.1e-06	0.000124	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	8.79e-06	0.000119	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—POMC—polycystic ovary syndrome	8.77e-06	0.000119	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—INS—polycystic ovary syndrome	8.72e-06	0.000118	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—TH—polycystic ovary syndrome	8.69e-06	0.000118	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	8.67e-06	0.000118	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	8.45e-06	0.000115	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	8.44e-06	0.000115	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IGF1—polycystic ovary syndrome	8.43e-06	0.000115	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—AKT2—polycystic ovary syndrome	8.43e-06	0.000115	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	8.34e-06	0.000113	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	8.3e-06	0.000113	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PPARG—polycystic ovary syndrome	8.22e-06	0.000112	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	8.22e-06	0.000112	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—POMC—polycystic ovary syndrome	8.11e-06	0.00011	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—INS—polycystic ovary syndrome	8.07e-06	0.00011	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	8.04e-06	0.000109	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.01e-06	0.000109	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	7.95e-06	0.000108	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	7.93e-06	0.000108	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	7.91e-06	0.000107	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—INS—polycystic ovary syndrome	7.88e-06	0.000107	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	7.87e-06	0.000107	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	7.75e-06	0.000105	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	7.66e-06	0.000104	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	7.5e-06	0.000102	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	7.09e-06	9.64e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	6.99e-06	9.5e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	6.76e-06	9.19e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—TH—polycystic ovary syndrome	6.71e-06	9.12e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	6.52e-06	8.87e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—IL6—polycystic ovary syndrome	6.45e-06	8.77e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	6.41e-06	8.71e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	6.22e-06	8.45e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	6.13e-06	8.34e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	6.13e-06	8.33e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—INS—polycystic ovary syndrome	6.1e-06	8.29e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	5.97e-06	8.12e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	5.67e-06	7.7e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	5.59e-06	7.6e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—INS—polycystic ovary syndrome	5.56e-06	7.56e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.51e-06	7.49e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	5.47e-06	7.44e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	5.22e-06	7.09e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	4.94e-06	6.72e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	4.84e-06	6.58e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	4.78e-06	6.49e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—INS—polycystic ovary syndrome	4.75e-06	6.46e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	4.61e-06	6.27e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL6—polycystic ovary syndrome	3.81e-06	5.18e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	3.74e-06	5.08e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	3.69e-06	5.01e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—INS—polycystic ovary syndrome	3.67e-06	4.98e-05	CbGpPWpGaD
